Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
“Bespreek SUDEP met alle epilepsiepatiënten”
aug 2019 | Epilepsie